Viviane Hess

Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment

Viviane Hess, Roger A’Hern, Nazar Nasiri et al. · Journal of Clinical Oncology · 2004 · 325 citations · Full text

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

Viviane Hess, Bengt Glimelius, Philipp Grawe et al. · The Lancet Oncology · 2008 · 235 citations

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +6

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Dieter Koeberle, Daniel Betticher, Roger von Moos et al. · Annals of Oncology · 2015 · 139 citations · Full text

Sakk 41/06, Gastrointestinal Oncology, Medicine +9

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Markus Borner, Dieter Koeberle, Roger von Moos et al. · Annals of Oncology · 2008 · 127 citations · Full text

Swiss Group, Oncology, Gastrointestinal Oncology +10

Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)

Thomas Ruhstaller, Miklos Pless, Daniel Dietrich et al. · Journal of Clinical Oncology · 2011 · 105 citations · Full text